The proposal would enable doctors and other medical professionals who prescribe mifepristone, misoprostol and generic alternatives – drugs used to abort a pregnancy in early stages – to be identified ...
Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.